Structural Characterisation of the Beta-Ketoacyl-Acyl Carrier Protein Synthases, FabF and FabH, of Yersinia pestis

被引:23
作者
Nanson, Jeffrey D. [1 ]
Himiari, Zainab [1 ]
Swarbrick, Crystall M. D. [1 ,2 ]
Forwood, Jade K. [1 ,2 ]
机构
[1] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia
[2] Charles Sturt Univ, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW 2678, Australia
来源
SCIENTIFIC REPORTS | 2015年 / 5卷
关键词
CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; III FABH; CONDENSING ENZYMES; INHIBITOR; THIOLACTOMYCIN; IDENTIFICATION; PLATENSIMYCIN; PURIFICATION;
D O I
10.1038/srep14797
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Yersinia pestis, the causative agent of bubonic, pneumonic, and septicaemic plague, remains a major public health threat, with outbreaks of disease occurring in China, Madagascar, and Peru in the last five years. The existence of multidrug resistant Y. pestis and the potential of this bacterium as a bioterrorism agent illustrates the need for new antimicrobials. The beta-ketoacyl-acyl carrier protein synthases, FabB, FabF, and FabH, catalyse the elongation of fatty acids as part of the type II fatty acid biosynthesis (FASII) system, to synthesise components of lipoproteins, phospholipids, and lipopolysaccharides essential for bacterial growth and survival. As such, these enzymes are promising targets for the development of novel therapeutic agents. We have determined the crystal structures of the Y. pestis beta-ketoacyl-acyl carrier protein synthases FabF and FabH, and compared these with the unpublished, deposited structure of Y. pestis FabB. Comparison of FabB, FabF, and FabH provides insights into the substrate specificities of these enzymes, and investigation of possible interactions with known beta-ketoacyl-acyl carrier protein synthase inhibitors suggests FabB, FabF and FabH may be targeted simultaneously to prevent synthesis of the fatty acids necessary for growth and survival.
引用
收藏
页数:13
相关论文
共 54 条
[21]   Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis [J].
Guiyoule, A ;
Gerbaud, G ;
Buchrieser, C ;
Galimand, M ;
Rahalison, L ;
Chanteau, S ;
Courvalin, P ;
Carniel, E .
EMERGING INFECTIOUS DISEASES, 2001, 7 (01) :43-48
[22]   Purification, characterization, and identification of novel inhibitors of the β-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus [J].
He, X ;
Reynolds, KA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1310-1318
[23]   Roles of the FabA and FabZ beta-hydroxyacyl-acyl carrier protein dehydratases in Escherichia coli fatty acid biosynthesis [J].
Heath, RJ ;
Rock, CO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) :27795-27801
[24]   Crystal structure of β-ketoacyl-acyl carrier protein synthase II from E-coli reveals the molecular architecture of condensing enzymes [J].
Huang, WJ ;
Jia, J ;
Edwards, P ;
Dehesh, K ;
Schneider, G ;
Lindqvist, Y .
EMBO JOURNAL, 1998, 17 (05) :1183-1191
[25]   Isolation and structure of platencin: A FabH and FabF dual inhibitor with potent broad-spectrum antibiotic activity [J].
Jayasuriya, Hiranthi ;
Herath, Kithsiri B. ;
Zhang, Chaowei ;
Zink, Deborah L. ;
Basilio, Angela ;
Genilloud, Olga ;
Diez, Maria Teresa ;
Vicente, Francisca ;
Gonzalez, Ignacio ;
Salazar, Oscar ;
Pelaez, Fernando ;
Cummings, Richard ;
Ha, Sookhee ;
Wang, Jun ;
Singh, Sheo B. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (25) :4684-4688
[26]   XDS [J].
Kabsch, Wolfgang .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2010, 66 :125-132
[27]   Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae β-ketoacyl-acyl carrier protein synthase III (FabH) [J].
Khandekar, SS ;
Gentry, DR ;
Van Aller, GS ;
Warren, P ;
Xiang, H ;
Silverman, C ;
Doyle, ML ;
Chambers, PA ;
Konstantinidis, AK ;
Brandt, M ;
Daines, RA ;
Lonsdale, JT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) :30024-30030
[28]   Structure-activity relationships at the 5-position of thiolactomycin:: An intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coli [J].
Kim, P ;
Zhang, YM ;
Shenoy, G ;
Nguyen, QA ;
Boshoff, HI ;
Manjunatha, UH ;
Goodwin, MB ;
Lonsdale, J ;
Price, AC ;
Miller, DJ ;
Duncan, K ;
White, SW ;
Rock, CO ;
Barry, CE ;
Dowd, CS .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (01) :159-171
[29]   Risk of person-to-person transmission of pneumonic plague [J].
Kool, JL .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (08) :1166-1172
[30]   Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis [J].
Kremer, L ;
Douglas, JD ;
Baulard, AR ;
Morehouse, C ;
Guy, MR ;
Alland, D ;
Dover, LG ;
Lakey, JH ;
Jacobs, WR ;
Brennan, PJ ;
Minnikin, DE ;
Besra, GS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) :16857-16864